Optimizing treatment for diabetic macular edema during cataract surgery

Area of Science:

• Ophthalmology
• Diabetology
• Retinal Diseases

Background:

• Diabetic macular edema (DME) is a leading cause of vision loss in diabetic retinopathy (DR).
• Diabetes mellitus is a global epidemic, increasing the risk of DR and DME.
• Cataract surgery in DME patients carries a high risk of vision deterioration due to DME progression.

Purpose of the Study:

• To review evidence on managing DME in patients undergoing cataract surgery.
• To guide ophthalmologists on effective and safe perioperative therapies for DME.
• To address the clinical conundrum of concurrent DME and visually significant cataract.

Main Methods:

• Review of clinical trials and scientific evidence on DME therapies.
• Analysis of perioperative treatments, including corticosteroids and anti-VEGF agents.
• Evaluation of inflammation's role in DME progression post-cataract surgery.

Main Results:

• Perioperative anti-inflammatory eye drops can reduce new-onset DME post-surgery.
• Managing concurrent DME during cataract surgery is complex.
• Intravitreal corticosteroids and anti-VEGF have shown efficacy in DME treatment and prevention of worsening.

Conclusions:

• Effective perioperative management is vital for DME patients undergoing cataract surgery.
• Therapies like intravitreal injections are key to preventing DME progression and visual decline.
• Further research guides ophthalmologists in optimizing patient care and visual outcomes.